Metsandia

Mometasone furoate, the active ingredient in Metsandia, is a corticosteroid presented as a nasal spray for nasal use. It reduces inflammation in the nasal passages and is indicated for the treatment of allergic rhinitis and nasal polyps in adults and children.

GNH USA supplies Metsandia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable global distribution.

Metsandia (mometasone furoate) is a topical corticosteroid used to manage inflammatory conditions of the nasal mucosa.

Allergic rhinitis: relief of nasal congestion, itching, sneezing and rhinorrhea. Nasal polyps: reduction of polyp size and improvement of nasal airflow. Seasonal allergic rhinitis: control of symptoms during pollen season.

Metsandia may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Throat irritation or dryness - Cough - Altered taste perception

Serious or Rare Side Effects: - Adrenal suppression with prolonged use - Severe allergic reaction (anaphylaxis) - Fungal infection of the nasal passages - Vision changes or cataract formation - Perforated nasal septum - Opportunistic infections due to local immunosuppression

Before using Metsandia, consider the following safety measures.

Pregnancy: consult a healthcare provider; safety not fully established. Breastfeeding: weigh potential benefits against unknown risks. Use in children: follow prescriber guidance; safety profile established for approved ages. Avoid concurrent use of other nasal decongestant sprays to reduce irritation risk. Monitor for signs of infection, unusual bleeding, or severe local reactions. Store at room temperature: keep in the original container, protect from moisture and heat.

Metsandia can interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure. - Live vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antifungal nasal sprays: may alter absorption of mometasone. - Antihistamines: additive sedation is uncommon but monitor patient response. - Nasal saline solutions: generally safe but assess for irritation when combined.